Senior Business Systems Analyst at Alector

South San Francisco, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Proven ability working on validated applications in a pharmaceutical or regulated environment, and Veeva experience. Veeva Vault certification required
Experience and knowledge of the quality, clinical and regulatory business processes
Direct hands-on experience implementing GxP computerized systems and maintaining systems in a validated state
Strong process improvement skills
Strong database experience. Snowflake experience and certification are desirable
Strong reporting and analytical skills using technologies like Power BI, Tableau, Spotfire etc
Master Data Management experience is desirable
Must have demonstrated business and technology skills with success in providing technology solutions
System Administration experience with the Veeva Vault Platform and Vault Safety
Experience with FDA E2B (R3) Safety Gateway, Signal Detection and Medical Information/Safety integration
Experience with other regulated applications, such as ComplianceWire Learning Management Systems, Statistical Computing (SAS) and other Veeva Vault systems
Database and Computer Networking Knowledge
Experience in maintenance and support of SaaS Systems
Experience with Reporting and Analytics platforms and tools

Responsibilities

Provide Operational Support (includes management of system access and permissions and monitor health of GxP systems)
Perform change management activities per established Change management procedures
Engage with users and the Veeva technical team to analyze and resolve issues
Maintain Systems and systems Operations/Administration documentation
Analyze user enhancement requests to deliver solutions focused on establishing and improving business processes that improve efficiency, address process gaps, and enable automation and growth of the organization
Taking ownership of new system implementations and systems enhancements projects
Taking ownership of GxP Systems support
Taking ownership of data compilation tasks (eg. Medical Affairs data extracts)
Taking ownership of Systems Change processes

Skills

Key technologies and capabilities for this role

Veeva Vault PlatformVault SafetyFDA E2B R3Safety GatewaySignal DetectionComplianceWireGxP SystemsChange ManagementSystem Administration

Questions & Answers

Common questions about this position

What experience is required with Veeva systems for this role?

Veeva Vault certification is required, along with experience with the Veeva Vault Platform and Vault Safety, FDA E2B (R3) Safety Gateway, Signal Detection, and Medical Information/Safety integration.

What is the salary or compensation for the Senior Business Systems Analyst position?

This information is not specified in the job description.

Is this a remote position, or is there a location requirement?

This information is not specified in the job description.

What key skills are needed besides Veeva experience?

Candidates need direct hands-on experience implementing GxP computerized systems, strong process improvement skills, strong database experience (Snowflake desirable), and strong reporting and analytical skills using tools like Power BI or Tableau.

What makes a strong candidate for this Senior Business Systems Analyst role?

A strong candidate has proven experience in pharmaceutical or regulated environments with validated applications, Veeva Vault certification, knowledge of quality, clinical, and regulatory processes, and skills in GxP systems, process improvement, databases, and analytics.

Alector

Develops therapies for neurodegenerative diseases

About Alector

Alector develops therapies aimed at treating neurodegenerative diseases like Alzheimer's and Parkinson's. The company focuses on research and development of new drug candidates by utilizing knowledge from immunology, neurology, and human genetics. Their approach involves conducting early-stage clinical trials to gather specific data about diseases, which helps improve the chances of success for their treatments. Alector differentiates itself from competitors by emphasizing the body's natural healing processes in their drug development. The company's goal is to create effective treatments for conditions that currently have limited options, while also attracting funding and partnerships through their research findings.

San Francisco, CaliforniaHeadquarters

2013Year Founded

$189.2MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Risks

Failure in AL002 trial may decrease investor confidence and financial stability.

Reliance on external financing increases financial risk if therapies don't succeed commercially.

Increased competition in neurodegenerative market could impact Alector's market share.

Differentiation

Alector combines antibody technology with neuroimmunology for novel neurodegenerative therapies.

Strategic alliance with Adimab enhances Alector's antibody discovery and optimization capabilities.

Focus on genetically validated therapies aligns with personalized medicine trends.

Upsides

Increased interest in neuroimmunology boosts investment and collaboration opportunities for Alector.

AI-driven drug discovery enhances efficiency, aligning with Alector's technology-driven strategy.

Expansion of strategic alliances offers collaboration and resource sharing opportunities for Alector.

Land your dream remote job 3x faster with AI

Try Jobo Free